# Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male Participants

> **NCT01520142** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 19 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** JNJ-26528398
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01520142
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2013-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520142, "Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01520142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*